Introduction
Ischemic heart disease is the leading cause of death worldwide, causing about 8.8 million deaths in 2015 and accounting for approximately 15 .5% of all deaths that year (1) . Prompt revascularization by percutaneous coronary intervention or bypass surgery markedly reduces acute mortality from myocardial infarction (MI); however, increased morbidity due to ischemic heart failure has become a global burden (2) , highlighting the need for additional therapeutic modalities to alleviate postischemic cardiovascular remodeling.
Evidence indicates that endothelial dysfunction is a key component of the pathophysiology of heart failure (3, 4) . VEGF-A, referred to herein as VEGF, is highly expressed in myocardial cells. While VEGF helps preserve the cardiac capillary bed under homeostatic conditions, it acts as a stimulating factor for angiogenesis, vascular leakage, and inflammation under ischemic conditions (5) (6) (7) (8) (9) (10) (11) . VEGF is downregulated during the transition from compensated hypertrophy to decompensated heart failure, reducing its capacity to preserve the cardiac capillary bed or to generate new vessels in response to cardiac hypertrophy (3) . Although a multitude of animal studies have shown that VEGF induces angiogenesis in the ischemic myocardium and that it mitigates adverse remodeling, to date, clinical trials of VEGF have not yet demonstrated any clinical benefits (5) . This discrepancy is likely due to the negative effect of VEGF on the ischemic heart. Indeed, VEGF exacerbates tissue damage after MI (6) and ischemic stroke (7) by inducing the disintegration of endothelial cells (ECs), thereby aggravating vascular leakage, inflammation, and hypoxia (8) . Inhibiting VEGF-induced vascular permeability can reduce tissue edema and improve outcome in MI (8) and stroke (7) . However, due to the angiogenic and cytoprotective effects of VEGF (9) , VEGF inhibition after MI confronts a major hurdle that can exacerbate ischemia and therefore tissue damage.
Angiopoietins, the other family of major angiogenic growth factors, regulate vascular maturation and stability by binding to the endothelial cell-specific (EC-specific) Tie2 receptor and to subtypes of integrins (10, 11) . Angiopoietin-1 (Angpt1) is an agonistic ligand of Tie2 that maintains the quiescence and integrity of ECs (12) . In contrast, Angpt2 is a partial Tie2 antagonist or agonist that can modulate Angpt1/Tie2 signaling in context-dependent (10) and organ-specific manners (13) (14) (15) (16) . Hypoxia and inflammation induce Angpt2 expression on ECs (17) , which destabilizes endothelial integrity (18) . Although the deleterious effects of Angpt2 in augmenting vascular permeability and inflammation have been intensely investigated in sepsis and tumor angiogenesis (14) , the precise role of Angpt2 in ischemic heart disease remains poorly elucidated. Emerging reports show that Angpt2 is associated with a greater risk of all-cause and cardiovascular mortality in the general population (19) , with the deterioration of cardiac function in heart failure patients (20) , and with higher mortality in MI and cardiogenic shock patients (21, 22) . Given these meaningful findings, we investigated the role of Angpt2 in cardiac ischemia using mouse models. Our findings demonstrate that Angpt2 substantially exacerbates postischemic cardiovascular remodeling, including pericyte detachment, adhesion moleEmerging evidence indicates that angiopoietin-2 (Angpt2), a well-recognized vascular destabilizing factor, is a biomarker of poor outcome in ischemic heart disease. However, its precise role in postischemic cardiovascular remodeling is poorly understood. Here, we show that Angpt2 plays multifaceted roles in the exacerbation of cardiac hypoxia and inflammation after myocardial ischemia. Angpt2 was highly expressed in endothelial cells at the infarct border zone after myocardial infarction (MI) or ischemia/reperfusion injury in mice. In the acute phase of MI, endothelial-derived Angpt2 antagonized Angpt1/Tie2 signaling, which was greatly involved in pericyte detachment, vascular leakage, increased adhesion molecular expression, degradation of the glycocalyx and extracellular matrix, and enhanced neutrophil infiltration and hypoxia in the infarct border area. In the chronic remodeling phase after MI, endothelial-and macrophage-derived Angpt2 continuously promoted abnormal vascular remodeling and proinflammatory macrophage polarization through integrin α 5 β 1 signaling, worsening cardiac hypoxia and inflammation. Accordingly, inhibition of Angpt2 either by gene deletion or using an antiAngpt2 blocking antibody substantially alleviated these pathological findings and ameliorated postischemic cardiovascular remodeling. Blockade of Angpt2 thus has potential as a therapeutic option for ischemic heart failure. FOXO1 is an upstream regulator of Angpt2 expression in ECs of the border zone. We next investigated the spatiotemporal expression of forkhead box protein O1 (FOXO1), an upstream transcriptional regulator of Angpt2 expression in the ECs after MI (25) . In the sham-operated control mouse heart, neither ECs nor cardiomyocytes (CMs) expressed FOXO1 (Figure 2A ). In contrast, there was a striking increase in FOXO1 expression, which is known to protect CMs against ischemic insult through regulation of antioxidant genes, in CMs in the infarct border area of MI mice (26) . This increase was distinct 1 day after MI and then rapidly decreased (Figure 2, A and B) . Of particular note, FOXO1 expression was robustly increased and showed nuclear or nucleocytoplasmic localization in ECs at the border zone 2 days after MI, which correlates with the Angpt2 expression profile (Figure 2, A and B) . Immunoblot analysis demonstrated a consistent finding of increased FOXO1 expression after MI (Figure 2, C and D) . Indeed, concurrent Angpt2 expression and FOXO1 nuclear localization were observed in the ECs ( Figure 2E ). To investigate whether FOXO1 directly regulated Angpt2 expression in ECs, we generated Foxo1 iΔEC mice by crossing Foxo1 fl/fl mice (27) with VE-cadherin-Cre-ER T2 mice (28) (Figure 2F ), which depleted endothelial FOXO1 by approximately 85% (Supplemental Figure 2 , A-C). EC-specific deletion of Foxo1 using Foxo1 iΔEC mice markedly reduced Angpt2 expression in ECs ( Figure 2 , G and H). Taken together, these findings indicate that FOXO1 is a major transcriptional upstream regulator of Angpt2 expression in the ECs of murine ischemic hearts.
Angpt2 induces pericyte detachment from ECs of infarct border zone through antagonizing Angpt1/Tie2 signaling. Angpt2 is characterized by its context-dependent mode of action, which functions cule expression, glycocalyx and extracellular matrix (ECM) degradation, proinflammatory macrophage polarization, and adverse vascular remodeling. These findings identify Angpt2 as a potential promising therapeutic target in ischemic heart disease, and antibody-mediated inhibition of Angpt2 ameliorates cardiac hypoxia and inflammation after MI.
Results

Angpt2 is highly expressed in ECs at the infarct border zone after MI.
To determine the expression profile of Angpt2 in mouse heart after MI, we utilized a specific anti-Angpt2 antibody (23) . High Angpt2 expression was observed in the infarct border zone 3 days after MI, while no Angpt2 expression was observed in shamoperated hearts ( Figure 1A) . A high-magnification view showed that Angpt2 expression was confined mainly to ECs at the border zone ( Figure 1B ). Sequential observations of ECs in the expanding infarct border revealed that Angpt2 expression began on day 2, peaked on day 3, and was maintained at the peak level until day 7 after MI ( Figure 1, C and D) . In vivo reporter gene analysis using Angpt2-EGFP mice confirmed that the increased Angpt2 expression was confined to the ECs (Figure 1 , E and F). To further determine the identity of ECs expressing Angpt2, we utilized endothelial-lineage tracing mouse (VE-cadherin-Cre-ER T2 / Rosa-tdTomato, Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/ JCI99659DS1) and a marker for circuiting ECs (CD117) (24) . Lineage-tracing analysis revealed that Angpt2 is almost exclusively expressed in ECs residing in the heart, rather than circulating ECs expressing CD117 (Supplemental Figure 1, B and C) . Figure 3C ), which showed no significant differences between the Angpt2 iΔEC and WT mice. Heart ECs of sham-operated mice demonstrated robust Tie2 phosphorylation, which was markedly reduced after MI (Figure 3 , D and E). Of note, the reduction in Tie2 phosphorylation in ECs after MI was further exacerbated in Angpt1 iΔ/Δ mice, but was markedly mitigated in Angpt2 iΔEC mice (Figure 3 , D and E). These findings imply that Angpt2 acts as a Tie2 antagonist in the ischemic heart. Given that Angpt2-induced Tie2 inactivation causes pericytes to detach from ECs in inflammatory conditions (14, 25, 30) , we examined the ratio of pericyte coverage onto ECs of the border zone. As shown in Figure 3 , F and G, the ECs with high Angpt2 expression had 55% less pericyte coverage than the ECs with no or low Angpt2 expression. Consistently, pericyte detachment from ECs of the border zone at 3 days after MI was reduced by 59% in Angpt2 iΔEC mice compared with WT mice (Figure 3, H and I) , suggesting the disintegrative role of Angpt2 in the microvasculature of the ischemic heart. as a Tie2 agonist in the absence of Angpt1, but as an antagonist in the presence of Angpt1 (14) . Therefore, we investigated the expression of Angpt1 in the heart using Angpt1-GFP reporter mice (29) . In sham-operated control mice, Angpt1 expression marked by GFP fluorescence was found to be heterogeneous, but distinctly expressed throughout the myocardium, but the expression was not apparently changed at 3 days after MI in surviving myocardium ( Figure 3, A Figure 3C ). Littermates that were Cre-ER T2 positive but flox/flox negative were defined as WT mice. Given the organ-specific role of Anpgt2 in the development and maturation of the vasculature, such as the vasculature of the kidney and Schlemm's canal of the eye (14, 15, 30-32), we investigated the systemic vascular function (Supplemental Figure 3, A and B) and Tie1 is an endothelial orphan receptor and a homolog of Tie2 that positively modulates Tie2 signaling (33, 34) . Given that Tie1 expression is reduced during inflammation and that this reduced Tie1 allows enhanced antagonistic action of Angpt2 against Tie2 (25, 34, 35) , we were curious about the expression level of the Tie1 protein in ECs of the border zone. Immunohistological analysis revealed that Tie1 was highly present in cardiac ECs of sham-operated control mice, but marked and gradual decline of Tie1 was detected at days 1 and 3 after MI ( Figure 3 , J and K). This finding implies that the antagonistic action of Angpt2 to Tie2 could be enforced in the ECs at the border zone. To further confirm the observed changes in immunofluorescence staining, expression of each protein after MI was investigated by immunoblotting or the immunoprecipitation method, which showed consistent results with immunostaining (Supplemental Figure 4 , A-D).
EC-derived Angpt2 exacerbates vascular leakage, cardiac hypoxia, and infarction. We and others recently reported that Angpt2 mediates vascular leakage in severe inflammatory conditions, leading to impairment of microvascular perfusion and organ damage (23, 36) . To investigate whether EC-derived Angpt2 and its Tie2-antagonizing action on ECs at the border zone contribute to vascular disintegration and infarct progression, Angpt2 iΔEC (gene deletion efficiency, ~93%; Supplemental Figure 5 and Supplemental Table 1 ) and WT mice were subjected to the MI procedure or to a sham procedure, and vascular leakage, perfusion, hypoxic molecule expression, and the infarct size were compared 3 days after surgery. Vascular leakage of low-molecular weight (40 kDa) dextran from the border zone microvasculature was markedly reduced, by 71%, iΔ/Δ and Tie2 iΔEC mice were also subjected to MI or sham procedure, and the impact of the deletion of either gene on vascular leakage and hypoxia was investigated. We generated Tie2 iΔEC mice by crossing Tie2 fl/fl mice (37) with VE-cadherin-Cre-ER T2 mice (28) (Supplemental Figure 6A ) and depleted Tie2 in a tamoxifeninducible manner (deletion efficiency, ~94%; Supplemental Figure 5 and Supplemental Table 1 ). Leakage of RBCs and expression of GLUT-1, another marker for hypoxia (38) , were signifi- of Angpt2 in the recruitment of inflammatory cells by increasing adhesion molecules in the ECs of other tissues and organs (14, 25, 35) , we decided to investigate the effect of EC-derived Angpt2 on vascular inflammation after MI using Angpt2 iΔEC mice. Adhesion molecules were abundantly expressed in ECs 3 days after MI, including E-selectin, L-selectin, VCAM-1, and ICAM-1 ( Figure  5 , A and B, and Supplemental Figure 7 , A and B). Interestingly, Angpt2 iΔEC mice showed lower (40%-63%) expression of these adhesion molecules; consequently, Gr-1 + neutrophil infiltration was 52% lower than in WT mice ( Figure 5, A and B) . Notably, increased expression of the NF-κB p65 protein on ECs, a major transcriptional factor for inflammation that is suppressed by Tie2 signaling in quiescent ECs (30) , was remarkably attenuated in Angpt2 iΔEC mice compared with WT mice ( Figure 5, A and B) , endorsing the exacerbating role of Angpt2 on vascular inflammation through the upregulation of NF-κB activity after MI. Accordingly, expression levels of E-selectin in ECs at the border zone were further aggravated by conditional deletion of Angpt1 (Angpt1 Heparan sulfate (HS) is a major component of the endothelial glycocalyx (eGC) and cardiac ECM (cECM). HS is degraded by heparanase, which is upregulated and activated by NF-κB activation during inflammation (40, 41) , and suppressed by Tie2 activation (23) . Therefore, we asked whether ECderived Angpt2 and subsequent upregulation of NF-κB p65 expression and perturbation of Tie2 activity play roles in eGC and cECM degradation by enhancing heparanase activity in ECs after MI. Indeed, heparanase expression was markedly increased in ECs at the border zone and in the surrounding infiltrated CD45 + leukocytes 3 days after MI, while no heparanase was detected in the hearts of sham-operated control mice ( Figure 6 , A and B). Immunoblot analyses also demonstrated marked upregulation of both inactive and active heparanase at the infarct border after MI ( Figure 6 , C and D). Using ImageJ software (NIH), we defined each HS of eGC or cECM, termed HS-eGC and HS-cECM, respectively (Supplemental Figure 8, A and B) . Well-aligned distributions of HS-eGC and HS-cECM were detected in hearts of normal and sham-operated control mice ( Figure 6E and Supplemental Figure 8A ). Compared with sham-operated control heart, severe losses and disorganizations of total HS, HS-eGC, and HS-cECM were detected in the ischemic regions of hearts 3 days after MI ( Figure 6 , E and F, Supplemental Figure 8B ). However, compared with WT MI mice, Angpt2 iΔEC MI mice showed reduced heparanase levels (~57%) and preserved total HS (~52%), HS-eGC (~59%), and HS-cECM (~26%) in the ischemic region 3 days after MI ( Figure 6 , E and F), suggesting a close correlation between the Angpt2-mediated heparanase expression and HS degradation on the eGC and ECM. On the other hand, expression of heparanase in ECs at the border zone and infiltrated leukocytes were further exaggerated in Angpt1 iΔ/Δ mice and Tie2 iΔEC mice compared with WT mice (Supplemental Figure  9, A and B) , implying the suppressive role of endothelial Tie2 on heparanase expression in ischemic heart. Together, these results iΔEC (T2ΔE) mice were subject to MI or sham procedure, hearts were harvested at 3 days after MI, and indicated molecules in heart sections at the infarct border were detected by immunostaining. (A and B) Images and comparisons of E-selectin, VCAM-1, and NF-κB p65 on ECs and Gr-1 + neutrophil infiltration in the infarct border. n = 5-6, each group. Scale bars: 50 μm, except for Gr-1 + neutrophil infiltration (500 μm). (C and D) Images and comparisons of E-selectin expression on ECs at the infarct border. n = 5-6, each group. Scale bars: 100 μm. *P < 0.025, Kruskal-Wallis test followed by Mann-Whitney U test for post hoc pairwise comparisons. Error bars represent mean ± SD. (42) . In particular, proinflammatory M1-like macrophages promote tissue damage and adverse cardiac remodeling after MI (43) . In contrast, those with antiinflammatory properties, termed M2-like macrophages, mitigate myocardial injury (44) . Histological analysis of the infarct border in MI mice revealed unexpected but distinct Angpt2 expression in CD68 + macrophages 7 days after MI ( Figure  7, A and B) . This is in accordance with previous in vitro findings (45) that hypoxia-induced HIF-1α promotes Angpt2 expression by macrophages. Notably, approximately 93% of Angpt2 + macrophages coexpressed inducible NOS (iNOS), a proinflammatory marker ( Figure 7A ). We therefore questioned whether Angpt2 plays a substantial role in macrophage polarization. However, the infiltrated macrophages hardly expressed Tie2 ( Figure 7C ). On the other hand, Angpt2 is known to induce the phosphorylation of ERK-and FAK-signaling pathways by binding to integrins α v β 3 , α v β 5 , and α 5 β 1 in Tie2-low or Tie2-negative cells (11) , and ERK activation induces the proinflammatory polarization of macrophages (46) . Intriguingly, CD68 + cardiac macrophages highly expressed integrin α 5 β 1 (Figure 7, C and D) , most of which colocalized with Angpt2 ( Figure 7E ). Therefore, we reasoned that Angpt2 might play an important role in polarizing macrophages toward a proinflammatory state by bind- Figure 6 . EC-specific depletion of Angpt2 mitigates degradation of eGC and ECM in ischemic heart. Adult WT or Angpt2 iΔEC mice were subject to MI or sham procedure, hearts were harvested at 3 days after MI, and indicated molecules in heart sections at the infarct border were detected by immunostaining. (A and B) Images and comparisons showing increased heparanase in ECs and infiltrating CD45 + leukocytes. n = 5-6, each group. Scale bars: 50 μm. *P < 0.05 versus sham, Mann-Whitney U test. (C and D) Immunoblot and densitometric analyses of heparanase expression and activation at the infarct border after MI. n=3, each group. *P < 0.05 versus sham, Mann-Whitney U test. (E and F) Images and comparisons of heparanase expression, HS-eGC density, and HS-cECM density. n = 5-6, each group. Scale bars: 50 μm. *P < 0.025, Kruskal-Wallis test followed by Mann-Whitney U test for post hoc pairwise comparisons. Error bars represent mean ± SD. Figure  8A ). Expression of iNOS and MHC II in CD68 + macrophages was reduced in Angpt2 iΔ/Δ mice by approximately 57% and approximately 56%, respectively, while the expression of CD206 and arginase-1 (Arg-1), which are antiinflammatory markers, was not significantly different, resulting in a decreased iNOS/CD206 ratio ( Figure 8 , B and C). Treatment of integrin α 5 β 1 -inhibitory peptide also remarkably mitigated iNOS expression in CD68 + macrophages, by 69% (Figure 8, D-F) . Taken together, these findings suggest that Angpt2/ ing to the integrin α 5 β 1 receptor and activating ERK. Indeed, ERK phosphorylation, as determined by phosphospecific antibody recognition of ERK1/2 (Thr202/Tyr204), was observed in most of the Angpt2 + macrophages (~95%) ( Figure 7F ). Therefore, we supposed that the upregulated Angpt2 expression in macrophages and ECs 
Angpt2 continuously drives adverse vascular remodeling in the infarct border zone.
We further investigated whether Angpt2 has a sustained effect on vascular remodeling by analyzing the infarct border zone 2 and 3 weeks after MI. Of special note, Angpt2 expression was still high in the ECs at these time points (Figure 9, A and B) . Notably, severely disorganized or disintegrated vessels at the border integrin α 5 β 1 signaling plays an important role in establishing an inflammatory microenvironment after myocardial ischemia by promoting proinflammatory macrophage polarization.
To elucidate whether macrophage-or endothelial-driven Angpt2 plays a major role in macrophage polarization, we generated Angpt2 ΔMΦ mice by crossing Angpt2 fl/fl mice (27) with LysM-Cre mice (48) (Supplemental Figure 10, A-C) . Macrophage-specific depletion of Angpt2 markedly diminished ERK phosphorylation and proinflammatory macrophage polarization, while EC-specific To gain insights into the mechanisms involved in Angpt2-induced vascular remodeling, we examined the expression of putative receptors and signaling molecules downstream of Angpt2. Of note, strong expression of integrin α 5 β 1 , which is not expressed in ECs of sham-operated control hearts, was observed in ECs at border zones of chronic ischemic hearts of WT and Angpt2 iΔ/Δ mice ( Figure  9 , F and G). FAK phosphorylation, as detected by phosphospecific antibody recognition of the Tyr397 autophosphorylation site of FAK (pFAK-Tyr 397), was observed on the vessels of WT mice that were undergoing remodeling, but the level was substantially lower in Angpt2 iΔ/Δ mice (Figure 9 , F and G). The integrin dependence of Angpt2-induced FAK phosphorylation was further confirmed by knockdown of integrin α 5 or integrin β 1 from HUVECs, which led to diminished Angpt2-induced FAK phosphorylation ( Figure 9H ). Given that FAK significantly contributes to formation of abnormal zone exhibited higher Angpt2 levels and distinct FOXO1 nuclear localization ( Figure 9 , A-C), indicating that disrupted ECs retained activated FOXO1 transcriptional activity and thereby increased Angpt2 expression in a positive feedback manner. Compared with sham-operated control hearts, marked impairments of NG2 + pericyte coverage, collagen type IV + (Col IV) basement membrane, and ZO-1 + tight junction on the ECs were detected at the infarct border zone 2 weeks after MI. To investigate whether Angpt2 from any source, i.e., from either ECs or from polarized macrophages, plays a role in chronic vascular remodeling, we used Angpt2 iΔ/Δ mice rather than Angpt2 iΔEC mice. Compared with those from WT mice, the ECs of Angpt2 iΔ/Δ mice showed better NG2 + pericyte coverage (~37%), more Col IV + basement membrane (~40%), more ZO-1 + tight junctions (~47%), and greater FITC-lectin + perfusion (~62%) (Figure 9 , D and E, and Supplemental Figure 11, A and B) . observed in our study. Furthermore, the GSEA data revealed a decreased association with the GO term proteinaceous ECM in Angpt2 iΔ/Δ mice compared with WT mice (Figure 10A ), which is a resultant phenotype of EndoMT. These GSEA findings support the notion that Angpt2 plays a dominant role in exacerbating adverse vascular remodeling after MI.
Genetic or pharmacological inhibition of Angpt2 ameliorates postischemic cardiovascular remodeling. Finally, we asked whether genetic depletion or pharmacological inhibition of Angpt2 could mitigate infarct progression and consequent heart failure. Indeed, pericyte detachment, RBC leakage, heparanase expression, leukocyte infiltration, proinflammatory macrophage polarization, and vascular adverse remodeling were all effectively mitigated by anti-Angpt2 antibody treatment (23) (Figure 11,  A and B) . Furthermore, antibody-mediated neutralization of Angpt2 suppressed the excessive activation of integrin β 1 in the infarct border ECs, reinforcing our suggestion that Angpt2 activates integrin α 5 β 1 after MI (Supplemental Figure 12 ). Consequently, global depletion of Angpt2 or treatment with an anti-Angpt2 blocking antibody 6 hours after MI ( Figure 12A ) attenuated infarct progression by approximately 57% and approximately 43% at 3 weeks after MI, respectively ( Figure  12 , B and C). Cardiac fibrosis, as measured by fibronectin deposition 3 weeks after MI, was also consistently lower in Angpt2 iΔ/Δ mice (~60%) and in anti-Angpt2 antibody-treated mice (~42%) (Figure 12, D and E) .
To determine whether Angpt2 depletion/inhibition had a protective effect on cardiac function, we measured the left ventricular systolic function by echocardiography 3 weeks after MI ( Figure  12F ). Intriguingly, genetic depletion of Angpt2 or anti-Angpt2 antibody treatment effectively mitigated the decrease in ejection fraction (~49% and ~33%), stroke volume (~48% and ~37%), and cardiac output (~49% and ~36%), respectively (Figure 12, F and G) .
We also investigated whether Angpt2 plays a crucial role in cardiac ischemia/reperfusion (I/R) using a mouse model. Similarly to the spatiotemporal expression pattern in MI, distinct FOXO1 nuclear localization and Angpt2 expression by ECs was observed in the vasculature around the tumor by increasing EC migration and permeability (49) , these data imply that Angpt2 promotes adverse vascular remodeling through integrin α 5 β 1 binding and FAK phosphorylation in the ischemic heart.
To further evaluate the impact of Angpt2 on chronic vascular remodeling, we performed gene expression profiling on ECs of the border zone that were freshly isolated from infarcted hearts using 3′ mRNA sequencing (50, 51) . Intriguingly, gene set expression analysis (GSEA) showed the downregulation of genes related to the epithelial mesenchymal transition (EMT) in the ECs of Angpt2 iΔ/Δ mice relative to those of WT mice ( Figure 10 , A and B). mRNA expression of the genes (Col12a1, Wnt5a, Lamc2, Fstl3, Pcolce) involved in endothelial-to-mesenchymal transition (EndoMT) were also significantly decreased in the heart ECs of Angpt2 iΔ/Δ mice compared with those of WT mice ( Figure 10C and Supplemental Table 1 ). The EndoMT is a specialized form of EMT that is characterized by the loss of endothelial identity and the acquisition of mesenchymal and stem-like characteristics by ECs (52) . Notably, EndoMT contributes to the disintegration of the vascular barrier and to abnormal vascular remodeling of the brain microvasculature (53) , which are similar to the vascular changes Angpt2 in postischemic cardiovascular remodeling. We recently reported that the FOXO1/Angpt2 axis suppresses the endothelial PI3K/Akt-signaling pathway, the main downstream pathway for Tie2 that plays a vital role in maintaining vascular integrity, inducing vascular destabilization in a positive feedback manner (25) , and that it is central to the pathogenesis of sepsis (23), diabetic retinopathy (25) , and tumor vessel destabilization (38) . This study provides additional insights into the serious detrimental effects of the FOXO1/Angpt2 axis in exacerbating cardiac hypoxia and infarct progression by impairing effective perfusion of the ischemic border. Our study also highlights the substantial role of Angpt2-induced vascular inflammation in cardiovascular remodeling. In quiescent ECs, Angpt1/Tie2 signaling recruits an intracellular protein, A20-binding inhibitor of NF-κB activation 2 (ABIN2), which strongly inhibits the NF-κB pathway (25, 36) , whereas Angpt2 activates the NF-κB pathway to further aggravate vascular inflammation and augment adhesion molecule expression (17, 55) . Accordingly, this study demonstrated that Angpt2 substantially contributes to the upregulation of NF-κB p65 expression in ECs of the border zone and increases the expression of heparanase and adhesion molecules, leading to robust infiltration of inflammatory cells and disorganization/degradation of eGC and cECM. Furthermore, our data show the preferential expression of Angpt2 by proinflammatory macrophages and the colocalization of Angpt2 with a putative receptor, integrin α 5 β 1 , and its downstream effector, pERK. Previous studies have highlighted the crucial role of the ERK pathway in determining the characteristics of proinflammatory macrophages (46, 56) . Here, we show that genetic deletion or pharmacological inhibition of Angpt2/ reperfused area starting 2 days after the I/R injury (Supplemental Figure 13, A-D) . Moreover, Angpt2 substantially contributed to vascular barrier disruption, vascular inflammation, proinflammatory macrophage polarization, and adverse vascular remodeling after I/R injury, and this was markedly alleviated by anti-Angpt2 antibody treatment (Supplemental Figure 13, E and F) . Consequently, antiAngpt2 antibody treatment greatly mitigated left ventricular wall thinning and infarct progression after I/R injury ( Figure 12, H-J) .
Discussion
This study demonstrated that Angpt2 plays crucial roles in EC destabilization and remodeling in the infarct border zone after MI and provided insights into the contribution of Angpt2 to the proinflammatory milieu ( Figure 13 ). Intriguingly, EC-specific deletion of Angpt2 preserved endothelial barrier integrity and quiescence after MI; this led to improved cardiac oxygenation and marked reduction of the infarct area in the acute phase of MI. Moreover, global deletion of Angpt2 mitigated proinflammatory macrophage polarization and adverse vascular remodeling in the chronic remodeling phase. It was especially noteworthy that genetic or antibody-mediated pharmacological inhibition of Angpt2 markedly ameliorated cardiac hypoxia and inflammation and the consequent progression of heart failure.
This study demonstrates the distinct spatiotemporal expression profile of Angpt2 after MI and I/R, which, to date, has been obscure due to a lack of reliable antibodies (54) . Using our recently developed anti-Angpt2 antibody (23) , which is highly sensitive and specific to Angpt2, we demonstrate distinct expressions of Angpt2 on the ECs and proinflammatory macrophages after ischemia. This prompted us to further investigate the role of Figure 11 . Therapeutic inhibition of Angpt2 prevents vascular disintegration, permeability, inflammation, adverse remodeling, and proinflammatory macrophage polarization after MI. Fc or α-Angpt2 (α-A2) (20 mg/kg, intraperitoneally) was administered to WT mice at 6 hours after MI or sham procedure, followed by repeated injection of the same dose at 1 week intervals. (A and B Previous reports suggest the critical roles of the Angpt-Tie2 system in vascular remodeling (34, 55) and tumor angiogenesis (38) , but the precise role of Angpt2 in vascular remodeling in ischemic organs is not fully understood. This study demonstrates that Angpt2 promotes adverse vascular remodeling in ischemic hearts via the Angpt2/integrin α 5 β 1 /FAK-signaling pathway. We note that the infarct border vessels with disintegrated morphology highly expressed pFAK-Tyr 397 as well as Angpt2. FAK is a multifacetintegrin α 5 β 1 signaling decreases ERK phosphorylation and proinflammatory macrophage polarization, in accordance with the findings of an in vitro study (57) , which strongly suggests that Angpt2 elicits ERK phosphorylation and proinflammatory macrophage polarization after myocardial ischemia. Collectively, these results suggest that Angpt2 plays an integral role in establishing an inflammatory cardiac milieu by augmenting neutrophil infiltration and proinflammatory macrophage polarization. C, E, and G) Comparisons of indicated parameters. *P < 0.025, Kruskal-Wallis test followed by Mann-Whitney U test for post hoc pairwise comparisons. Significance was adjusted for multiple comparisons using Bonferroni's method. (H-J) Fc or α-Angpt2 (20 mg/kg, intraperitoneally) was administered to WT mice at 6 hours after I/R, followed by repeated injections of the same dose at 1 week intervals. Images of cardiac fibrosis determined by Masson trichrome stain and comparisons of indicated parameters. n = 6, each group. Scale bars: 1 mm. *P < 0.05 versus WT, Mann-Whitney U test. Error bars represent mean ± SD. a putative mechanism for Angpt2-induced vascular remodeling, and this is supported by the well-recognized augmenting role of FAK signaling in EMT/EndoMT progression (49) . Myocardial ischemia and the subsequent reperfusion induced by percutaneous coronary intervention or cardiac surgery after MI elicit a robust inflammatory response and cause additional damage to the heart, despite their myocardial salvaging effects (62, 63) . In this regard, mitigating inflammation and reperfusion injury after MI and subsequently reducing infarct size are the primary goals for preventing the initiation and progression of ischemic heart failure (39, 62) . Importantly, the expression and the deleterious effects of Angpt2, which augmented cardiac hypoxia and inflammation, were recapitulated in an I/R model, suggesting the integral role of Angpt2 in the pathogenesis of postischemic cardiovascular remodeling. While a previous report has shown that 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors may suppress the FOXO1/ Angpt2 axis through in vitro drug screening (64) , the exact mechanism remains unclear and the effects are yet to be demonstrated in vivo. Meanwhile, in our study, the antibody-mediated inhibition of Angpt2 considerably abrogated Angpt2-induced vascular disined regulator of intracellular signaling that is involved in processes such as cell motility, survival, and proliferation in various tumor cells and in the surrounding microenvironment components, including ECs (49) . Indeed, FAK plays a critical role in vascular remodeling, and orthotropic glioma implantation in Fak iΔEC mice results in tumor vessel normalization (58) , similar to the normalized morphology of the vessels in the infarct border area in Angpt2 iΔ/Δ mice. Together with normalization of vascular morphology, Angpt2 deletion led to marked reduction of pFAK-Tyr 397 expression in infarct border area vessels at the chronic remodeling phase, reinforcing the idea that Angpt2/integrin α 5 β 1 /FAK signaling is the main driver of vascular remodeling in ischemic conditions. The EndoMT is a fundamental step in the development of cardiac valves (59) , and interestingly, the emergence of cardiac pericytes and vascular smooth muscles cells derived from ECs through EndoMT has also been recognized (60) . Moreover, a recent study (61) showed that Angpt2 induces cerebral cavernous malformation through the EndoMT, and this was effectively normalized by an anti-Angpt2 blocking antibody. In accordance with these studies, our GSEA findings strongly suggest that the EndoMT serves as Figure 13 . Schematic diagram depicting the roles of Angpt2 in exacerbating cardiac hypoxia and inflammation after myocardial ischemia. Myocardial ischemia induces disintegration of endothelial barrier, abnormal vascular remodeling, robust inflammatory responses, and ECM disorganization, and these pathological changes can be effectively mitigated by Angpt2 blockade. Mechanistically, in ECs, the increase in Angpt2 expression is directly regulated by FOXO1, which antagonizes Tie2 signaling and consequently attenuates PI3K/Akt signaling and enhances NF-κB p65 and FOXO1 expression. Thus, increased FOXO1 transcriptional activity forms a positive feedback loop with Angpt2 and exerts a sustained effect on ECs, leading to destabilization and remodeling. Pericyte detachment and EC destabilization presumably due to attenuated PI3K/Akt signaling exacerbate vascular leakage. Enhanced activity of NF-κB p65 augments endothelial expression of heparanase and adhesion molecules, further promoting inflammatory cell recruitment and ECM disorganization. In addition, Angpt2/integrin α 5 β 1 signaling promotes abnormal vascular remodeling through FAK phosphorylation, resulting in chronic hypoxia. In macrophages, the Angpt2/ integrin α 5 β 1 /ERK-signaling pathway plays an important role in proinflammatory macrophage polarization in autocrine and paracrine manners. These exacerbating roles of Angpt2 in cardiac hypoxia and inflammation after myocardial ischemia eventually trigger deterioration of cardiac structure and function, leading to heart failure. jci.org Volume 128
Number 11 November 2018 opened in the third intercostal space, and permanent suture by 8-0 prolene was made for the MI procedure. Complete occlusion of the left anterior descending (LAD) artery was confirmed by the presence of myocardial blanching. For the I/R injury model, a 7-0 prolene suture was made with a section of PE-10 tubing placed over the LAD artery, 1 mm below the tip of the left atrium. After occlusion for 30 minutes, the ligature was released by removing PE-10 tubing for reperfusion of LAD. After permanent or temporary ligation of LAD, the chest wall was closed with 6-0 silk suture. Sham-operated mice underwent the same procedure without coronary artery ligation. Animals were not randomized; however, procedures were performed by researchers blinded to the genotype and drug-or antibody-treatment group. For more information, see Supplemental Methods.
Statistics. Values are presented as mean ± SD. Statistical differences between the means were compared by the 2-sided Mann-Whitney U test for 2 groups and by the Kruskal-Wallis test followed by Bonferroni's correction for multiple groups. Statistical analysis was performed with PASW Statistics 18 (SPSS). Statistical significance was set to a P value of less than 0.05.
Study approval. Animal care and experimental procedures were approved by the Animal Care Committee of KAIST (no. KA2013-40). Mice were housed in accordance with the Institutional Animal Care and Use Committee regulations at KAIST.
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SJL's present address is: Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea. tegration, vascular inflammation, proinflammatory macrophage polarization and adverse vascular remodeling, even when the antibody was injected 6 hours after MI or I/R to mimic a clinically relevant situation. Further, in line with evidence that hypoxia and inflammation play an important part in triggering and promoting tissue fibrosis (65), our findings highlight that pharmacological inhibition of Angpt2 markedly ameliorates cardiac fibrosis and decline in cardiac function after myocardial ischemia. These findings provide mechanistic insights that could enormously expand the therapeutic repertoire for ischemic heart disease.
Together, the results of this study elucidate the integral roles of Angpt2 in the pathogenesis of postischemic cardiovascular remodeling and designate Angpt2 as a promising therapeutic target, in which inhibition of Angpt2 markedly ameliorates cardiac hypoxia and inflammation and subsequently prevents ischemic heart failure.
Methods
Mice. Specific pathogen-free (SPF) C57BL/6J mice, Tie2-GFP mice, and UBC-Cre-ER T2 mice were purchased from the Jackson Laborato- mice. Tamoxifen (2 mg, T5648; Sigma-Aldrich) was injected intraperitoneally a total of 3 times every 2 days into the 4-week-old genetically modified mice, followed by an additional injection (2 mg) 2 weeks later. In the case of global deletion, considering the rapid turnover rate of macrophage life span of 10 to 14 days (67), tamoxifen (2 mg) was additionally given immediately before the procedure. Cre-ER T2 -positive but flox/flox-negative mice among the littermates for each experiment were defined as WT mice. Surgical procedures. Eight-to ten-week old male C57BL/6J WT or genetically modified mice were subjected to an MI or I/R injury model. Mice were anesthetized with isoflurane and intubated using a 20-gauge intravenous catheter with a blunt end and ventilated with a mixture of oxygen and isoflurane (1.5%-2.0%). The chest cavity was
